CONKLING WILLIAM bought TARA

January 16, 2026 · Form 4 insider transaction

CONKLING WILLIAM bought 26,000 shares of Protara Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
26,000
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after76,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

View the original Form 4 on SEC EDGAR